Inflation-adjusted annual cost of U.S. medical school attendance increased from $51,400 to $71,000 between 2008 and 2020.

FDA approves pembrolizumab and enfortumab vedotin for neoadjuvant and adjuvant treatment of cisplatin-ineligible muscle-invasive bladder cancer.

(HealthDay News) — One dose of bivalent or nonavalent human papillomavirus (HPV) vaccine is noninferior to two doses for protecting against HPV16 and HPV18 infection, according to a study published ...

Researchers explored the relationship between positive mental health literacy, job crafting, and job well-being in palliative care nurses. Job crafting mediates the relationship between positive ...

Both T1D and T2D independently associated with SCD, with the greatest risk difference seen for younger individuals.

In this cross-sectional analysis, researchers aimed to characterize the NIH trials affected by grant terminations under the Trump administration. More than 74,000 individuals were enrolled in active ...

Authors say widely available foods like tea, coffee, berries, olive oil, nuts, and whole grains may be a practical way to improve long-term cardiovascular disease risk.

(HealthDay News) — The oral small-molecule glucagon-like peptide 1 (GLP-1) receptor agonist orforglipron demonstrates superior weight loss as an adjunct to lifestyle modification versus placebo for ...

PSMAddition is an international, open-label, prospective, phase 3 randomized controlled trial of 177Lu-PSMA-617 plus ADT and ARPI in PSMA-positive mHSPC.

(HealthDay News) — Most speakers attending U.S. Food and Drug Administration (FDA) Human Drug Advisory Committee meetings about new drugs or indications support approval, according to a research ...

Having a longer travel time to their treatment facility improves survival in prostate cancer patients, according to a recent study.

No significant differences in mean cost of care or in 30-day readmission for home hospital versus brick-and-mortar hospital care.